Drug details

Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol)

type of Beta2 Agonists, Anticholinergic Agents

Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate) is a combination of an inhaled corticosteroid, an anticholinergic, and a long-acting beta2-adrenergic agonist (LABA), indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

The drug is often used to treat Chronic obstructive pulmonary disease .

This drug may have the following side effects:

• diarrhea
• upper respiratory tract infection,
• back pain,
• cough,
• urinary tract infection (UTI),
• pneumonia,
• muscle spasm,
• oral thrush,
• influenza,
• sinusitis, and

The following drugs are related to Breztri Aerosphere, either as a replacement or used together:

• Duaklir Pressair (aclidinium bromide and formoterol fumarate inhalation powder)
• Anoro Ellipta (umeclidinium and vilanterol inhalation powder)
• Arnuity Ellipta (fluticasone furoate inhalation powder)
• Bevespi Aerosphere (glycopyrrolate and formoterol fumarate inhalation aerosol)
• Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)
• Symbicort (budesonide and formoterol fumarate dihydrate)
• Daliresp (roflumilast)
• Trelegy Ellipta (fluticasone furoate inhalation powder)
• Incruse Ellipta (umeclidinium inhalation powder)
• Striverdi Respimat (olodaterol inhalation spray)
• Yupelri (revefenacin inhalation solution)
• Stiolto Respimat (tiotropium bromide and olodaterol)